Clinical Trials in Arizona

Showing 1-20 of 14,395 trials

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

NCT07042100

This is a Phase 1 study of SBO-154 in patients with advanced cancers who are unable to tolerate or have not previously responded to standard therapy available in the country. The study involves multiple doses and takes place at several centers.

Advanced Solid Tumors

Sun Pharma Advanced Research Company Limited177 participantsStarted Aug 2025

Scottsdale, Arizona, United States • Santa Monica, California, United States • New Haven, Connecticut, United States +12 more locations

RECRUITING31 miles

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

NCT06433752

The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

Relapsing Multiple SclerosisMultiple Sclerosis

TG Therapeutics, Inc.2,000 participantsStarted Jul 2024

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +82 more locations

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Find Trials by Condition in Arizona

MitraClip REPAIR MR Study

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

Dissemination and Implementation of the Bright Bodies Intervention for Childhood Obesity

Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)